
Modeling new immunoregulatory therapeutics as antimicrobial alternatives for treating Clostridium difficile infection
Keywords: کلستریدیوم دیفیسیل; Clostridium difficile; In silico clinical trials; Gastrointestinal disease modeling; LANCL2; Immunoregulation;